Quantification Hands-on Workshop (DaTQUANT)

Ioflupane (­123I) - 20 years of DaT-SPECT imaging

22.12.2020

Organized by:

ge-healthcare-logo.jpg

Quantifying Ioflupane (123I) images using DaTQUANT™


DaTQUANT™ is a software tool that enables visual evaluation providing automated, reproducible, and accurate quantification capabilities. This semiquantitative “Hands on Experience” will provide insights focused on:
• More ways to manually adjust the ROI
placement,
• Importing compressed DICOM data from PACS,
• Customizing normal database graphs and table
of quantified values
• Easier comparison of serial/longitudinal studies
of the same subject


Ioflupane (123I) - 20 years of DaT-SPECT imaging


Markedly abnormal Ioflupane (123I) in one or both putamina is the diagnostic pattern for PD in patients with clinically confirmed PD. This pattern which has been helping to confirm the diagnosis in patients with unclear clinical presentations since 2000 will be presented and discussed in our round table with our guests.

 


Scientific Agenda


09:50 - 10:00 Welcome and Introduction


10:00 - 10:30 Diagnostic Imaging of Parkinson‘s Disease. What does the neurologist expect?
Dr. Athanasios Leonardos


10:30 - 11:00 Step Forward into Imaging with Ioflupane (123I)
Dr. Athanasios Natsios


11:00 - 12:30 DaT-SPECT - The value of a fast, effective and reproducible quantification
Bert Umland-Seidler

 

12:30 - 13:30 Break


13:30 - 15:00 Hands-on training
Bert Umland-Seidler


15:00 - 15:15 Q/A coffee break


15:15 - 16:45 Round table: Ioflupane (123I) - 20 years of DaT-SPECT imaging
Prof. Andreas Fotopoulos
Dr. Athanasios Leonardos
Bert Umland-Seidler -Application Specialist GEHC
Charalampos Bougias RT, MSc


16:45 - 17:00 Summary & Conclusions

Speakers

  1. Andreas Fotopoulos, Professor of Nuclear Medicine, Ioannina University, Greece

  2. Athanasios Leonardos, Movement Disorders Neurologist, National and Kapodistrian University of Athens, Division of Neurology I, Eginitio Hospital, Athens

  3. Athanasios Natsios, Medical Advisor SEE, GE Healthcare LSCI

  4. Bert Umland-Seidler, Application specialist GE Healthcare

  5. Charalampos Bougias, RT, MSc, Nuclear Medicine Department, Ioannina University, Greece

espa-banner.png